Jump to content
IndiaDivine.org

GMW:_phamrma_crops_increasing_in_US

Rate this topic


Guest guest

Recommended Posts

Guest guest

GMW:_phamrma_crops_increasing_in_US

" GM_Watch "

Wed, 2 Jun 2004 09:25:25 +0100

 

GM WATCH daily

http://www.gmwatch.org

---

There's more of them and nobody knows exactly where they are. Welcome to the

regulation of potent pharmaceuticals in food crops, US-style.

 

EXCERPTS: The USDA has approved slightly more than 300 biopharming plantings

throughout the country since 1995

 

The number of federal regulatory approvals and applications of these outdoor

plantings -- often called " biopharming'' -- have nearly doubled in the last 12

months, compared to the previous year.

 

Most applications... don't specify how many acres are to be cultivated and

exactly where the pharmaceutical crops are to be grown, making it impossible for

nervous conventional farmers to know whether biotech varieties that could

cross-pollinate with their harvest are growing nearby.

---

'Pharming' experiments on rise a year after setback

Tue, Jun. 01, 2004

http://www.duluthsuperior.com/mld/duluthsuperior/business/technology/8811681.htm

 

SAN FRANCISCO(AP) - Biotechnology companies are quietly pushing to splice more

human genes into growing numbers of food crops after the practice was nearly

left for dead last year, a Washington-based advocacy group will report

Wednesday.

 

The spike comes a little more than a year after a Texas company caused such

uproar with its accidental mixing of its " pharma " crops with conventionally

grown plants that giant food manufacturers called for tighter regulation of such

experiments and biotech titan Monsanto Co. announced it was abandoning the

field.

 

The number of federal regulatory approvals and applications of these outdoor

plantings -- often called " biopharming'' -- have nearly doubled in the last 12

months, compared to the previous year, according to a study to be released by

the Washington D.C.-based Center for Science in the Public Interest.

 

" The biopharming industry seems to be back in business,'' concluded the report,

which is based on publicly available U.S. Department of Agriculture data.

 

The USDA has approved seven of the 16 applications it received between May 2003

and April. The nine applications pending were all submitted in the last four

months, and the report's author Greg Jaffe expects those to be approved in the

coming weeks. That's because the USDA has denied only two such applications

since 2000, Jaffe said.

 

The USDA has approved slightly more than 300 biopharming plantings throughout

the country since 1995. As late as June 2002, it approved about 25 annually

before approvals fell to just four a year 12 months later.

 

No human drug made from genetically engineered crops has been approved for

commercial use and most applications are for small outdoor plots of less than

acre each, the USDA said.

 

Still, Jaffe and other critics complain that current USDA regulations are too

lax and not open enough to the public.

 

Most applications, for instance, don't specify how many acres are to be

cultivated and exactly where the pharmaceutical crops are to be grown, making it

impossible for nervous conventional farmers to know whether biotech varieties

that could cross-pollinated with their harvest are growing nearby.

 

Several small biotechnology companies and university researchers are attempting

to make inexpensive human medicines such as insulin and vaccines by splicing

protein-producing human genes into crops that include corn, rice and even

tobacco.

 

The human genes coax the crops to produce proteins, which can be extracted from

the plants and turned into medicines.

 

At Stanford University, 16 lymphoma patients last year were treated with an

experimental cancer drug extracted from a genetically engineered tobacco created

by Large Scale Biology Corp. -- the first human use of a pharmaceutical derived

from a plant.

 

This biotechnology niche had been growing steadily for a decade despite

continued attacks from genetic engineering foes who fear such work has not been

studied enough to ensure the safety of the nation's food supply if accidental

mixing occurs.

 

Pharming suffered a dramatic setback in late 2002 when the USDA fined College

Station, Texas-based Prodigene Inc. $500,000 and ordered it to pay another $3

million to buy and destroy conventionally grown soy contaminated with its corn,

which was genetically engineered to produce a pig vaccine.

 

Since then, Large Scale Biology has fallen on hard financial times and hasn't

continued with expanded lymphoma experiments.

 

The Grocery Manufactures of America, which supports biotech crops approved for

consumption and represents the Coca Cola Co., Nestle and dozens of others in the

$500 billion food industry, has called on the USDA to tighten regulation of

pharma crops and biotech companies to experiment exclusively with non-food

crops.

 

Last year, Monsanto Co., the world's largest biotech farming company, announced

it was abandoning the pharmaceutical field.

 

And in April, California regulators denied Sacramento-based Ventria BioScience's

application to grow rice with human genes after California rice growers said

they feared international customers would refuse to buy their conventionally

grown crops out of contamination fears.

 

In response to the growing concern, the USDA plans to unveil a revised review

process in the next three weeks that would make public more information on

pharma applications and, for the first time since 1998, require detailed

environmental assessments on large-scale projects near commercialization, said

Cindy Smith, the deputy administrator of biotech regulation for the department.

 

Smith said Prodigene will be the first company to undergo the more stringent

environmental review on the two applications it has pending to grow

pharmaceutical corn in Texas this year.

 

A Prodigene spokeswoman didn't return a telephone call.

 

 

 

 

 

 

 

 

 

Friends. Fun. Try the all-new Messenger

 

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...